Literature DB >> 18209779

Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience.

Paul R Yenson1, Eric M Yoshida, Charles H Li, Henry V Chung, Peter Wk Tsang.   

Abstract

BACKGROUND AND METHODS: Elevated serum ferritin is a common clinical finding. The etiology of hyperferritinemia in the Asia-Pacific population is less clear due to a low prevalence of known HFE mutations such as C282Y and H63D, as well as an increased prevalence of viral hepatitis and hereditary anemia. A retrospective case review of 80 patients of Asian ethnicity referred to three subspecialists in tertiary care teaching hospitals between January 1997 and March 2005 for assessment of hyperferritinemia was performed.
RESULTS: Only four patients (5%) had iron overload on liver biopsy or quantitative phlebotomy. Forty-nine patients (61%) had secondary causes for their hyperferritinemia, of which 26 had liver disease; 16 of those patients also had viral hepatitis. Thirteen patients fulfilled criteria for the insulin resistance syndrome. Other causes included hematological disorders (n=10), malignancy (n=2) and inflammatory arthritis (n=2). Twenty-seven cases (34%) of unexplained hyperferritinemia were found. Of a total of 22 patients who underwent liver biopsy, significant iron deposition was found in one patient. Fifteen patients underwent C282Y and H63D genotyping, with two cases of H63D heterozygosity. Fourteen patients had first-degree relatives with hyperferritinemia. Three families were identified with more than two members affected, which is suggestive of a possible hereditary hyperferritinemia syndrome.
CONCLUSION: Secondary causes of elevated ferritin in the Asian population, particularly liver disease, are common, but primary iron overload syndromes appear to be rare. In a significant proportion of patients, the etiology remains unexplained. The genetic basis for hyperferritinemia in Asians is poorly defined and requires further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209779      PMCID: PMC2659118          DOI: 10.1155/2008/245096

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  22 in total

1.  Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.

Authors:  Anne-Marie Jouanolle; Véronique Douabin-Gicquel; Chantal Halimi; Olivier Loréal; Patricia Fergelot; Thierry Delacour; Anne-Sophie de Lajarte-Thirouard; Bruno Turlin; Jean-Yves Le Gall; Estelle Cadet; Jacques Rochette; Véronique David; Pierre Brissot
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

2.  Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.

Authors:  M Simon; M Bourel; R Fauchet; B Genetet
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

3.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  A Chinese patient with non-HFE-linked iron overload.

Authors:  C Kng; F H Ng; W F Ng; B C Wong; L E Grosso; E M Brunt; B R Bacon
Journal:  J Clin Gastroenterol       Date:  2001-07       Impact factor: 3.062

Review 5.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.

Authors:  E H Hanson; G Imperatore; W Burke
Journal:  Am J Epidemiol       Date:  2001-08-01       Impact factor: 4.897

Review 6.  The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region.

Authors:  M Mortimore; A T Merryweather-Clarke; K J Robson; L W Powell
Journal:  J Gastroenterol Hepatol       Date:  1999-09       Impact factor: 4.029

Review 7.  Chronic hepatitis B virus infection in Asian countries.

Authors:  I Merican; R Guan; D Amarapuka; M J Alexander; A Chutaputti; R N Chien; S S Hasnian; N Leung; L Lesmana; P H Phiet; H M Sjalfoellah Noer; J Sollano; H S Sun; D Z Xu
Journal:  J Gastroenterol Hepatol       Date:  2000-12       Impact factor: 4.029

8.  The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients: multicentre retrospective study.

Authors:  W M Tsui; P W Lam; K C Lee; K F Ma; Y K Chan; M W Wong; S P Yip; C S Wong; A S Chow; S T Lo
Journal:  Hong Kong Med J       Date:  2000-06       Impact factor: 2.227

9.  Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

Authors:  P Brissot; M Bourel; D Herry; J P Verger; M Messner; C Beaumont; F Regnouard; B Ferrand; M Simon
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

10.  Serum ferritin and transferrin saturation in Asians and Pacific Islanders.

Authors:  Emily L Harris; Christine E McLaren; David M Reboussin; Victor R Gordeuk; James C Barton; Ronald T Acton; Gordon D McLaren; Thomas M Vogt; Beverly M Snively; Catherine Leiendecker-Foster; Joan L Holup; Leah V Passmore; John H Eckfeldt; Edward Lin; Paul C Adams
Journal:  Arch Intern Med       Date:  2007-04-09
View more
  3 in total

1.  HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population.

Authors:  Sang Hyub Lee; Jin-Wook Kim; So Hyun Shin; Kyoung Phil Kang; Hyun Cheol Choi; Sung Hee Choi; Kyoung Un Park; Hyun Young Kim; Weechang Kang; Sook-Hyang Jeong
Journal:  Dig Dis Sci       Date:  2008-08-06       Impact factor: 3.199

2.  Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis.

Authors:  Roberto Trasolini; Ben Cox; Ciaran Galts; Eric M Yoshida; Vladimir Marquez
Journal:  Can Liver J       Date:  2022-05-09

3.  Influence of ethnicity on biochemical markers of health and disease in the CALIPER cohort of healthy children and adolescents.

Authors:  Houman Tahmasebi; Shervin Asgari; Alexandra Hall; Victoria Higgins; Ashfia Chowdhury; Rebecca Thompson; Mary Kathryn Bohn; Joseph Macri; Khosrow Adeli
Journal:  Clin Chem Lab Med       Date:  2020-03-26       Impact factor: 8.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.